1[1]Liu YL, Stock MJ. Acute effects of the β3-adrenoceptor agonist, BRL 35135, on tissue glucose utilization [ J ]. Br J Pharmacol, 1995,114 (4):888-894.
2[2]Umekawa T, Yoshida T, Sakane N, et al. Anti-obesity and anti-diabetic effects of CL 316,243, a highly specific beta 3-adrenoceptor agonist,in otsuka long-evans tokushima fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in wbite fat[ J]. Eur J Endocrinol, 1997,136 (4): 429-437.
3[3]Hashimoto K, Nagao Y, Ida K, et al. Improvement of metabolic disorders and visceral fat obesity by the β3-adrenoceotor agonist( R * ,R* )-( ± )-methyl-4-[ 2-[ 2-hydroxy-2-( 3-chlorophenyl ) ethylamino ]propyl]-phenoxyacetate hydrobromide ( BRL 35135A ) in genetically obese rodents[J]. Biochem Pharmacol, 1996,52(10): 1529-1535.
4[4]Arbeeny CM, Meyers DS, Hillyer DE, et al. Metabolic alterations associated with the antidiabetic effect of β3-adrenergic receptor agonists in obese mice[ J]. Am J Physiol, 1995,268(4 Pt 1 ): E678-E684.
5[5]Liu YL,Cawthorne MA,Stock MJ.Biphasic effects of the β-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle [ J ]. Br J Pharmacol, 1996,117 (6): 1355-1361.
6[6]Grujic D, Susulic VS, Harper ME, et al. β3-adrenergic receptors on white and brown adipocytes mediate β3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake [ J ]. J Biol Chem, 1997,272 (28): 17686-17693.
7[7]Danforth E Jr, Himms-Hagen JH. Obesity and diabetes and the beta-3adrenergic receptor[ J ]. Eur J Endocrinol, 1997,136(4): 362-365.
8[8]Horm GJ, Forrest MJ, Bach TJ, et al. β3-adrenergic receptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeys[ J]. J Pharmacol Exp Ther,2001,297 (1): 299-307.
9[9]Oriowo MA. Atypical β-adrenoccptors in the rat isolated common carotid artery[J]. Br J Pharmacol, 1994,113(3) :699-702.
10[10]Gettys TW, Harkness PJ, Watson PM. The β3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes[J]. Endocrinology, 1996,137(9):4054-4057.
3OMACHI A, ISHIOKA K, UOZUMI A, et al. Beta3-adrenoceptor agonist AJ-9677 reduces body fat in obese beagles [ J ]. Res Vet Sci, 2007,839(1) :5 - 11.
4LECLERCQ IA,DA SILVA MORAIS A,et al, Insulin resisance in hepatocytes and sinusoidal liver cell: mechanisms and consequences [ J ]. J Hepatol,2007,47 ( 1 ) : 142 - 156.
5DARIMONT C, TURINI M ,EPITAUX M, et al. Beta3-adrenoceptor agonist prevents alterations of muscle diacylglycerol and adipose tissue phospholipids induced by a cafeteria diet[J]. Nutr Metab (Lond) ,2004,1 (1) :4.
6YAMAMOTO H,TAKAKURA S,YAMAMOTO T,et al. FR149175, a beta 3-adrenoceptor-selective agonist, is a possible therapeutic agent for non-insulin-dependent diabetes mellitus [ J3. Jpn J Pharmacol,1997,74( 1 ) :109 - 112.
